GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexicon Pharmaceuticals Inc (STU:LX31) » Definitions » Float Percentage Of Total Shares Outstanding

Lexicon Pharmaceuticals (STU:LX31) Float Percentage Of Total Shares Outstanding : 45.09% (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Lexicon Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lexicon Pharmaceuticals's float shares is 162.98 Mil. Lexicon Pharmaceuticals's total shares outstanding is 361.49 Mil. Lexicon Pharmaceuticals's float percentage of total shares outstanding is 45.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lexicon Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lexicon Pharmaceuticals's Institutional Ownership is 10.78%.

Lexicon Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Lexicon Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=162.98/361.49
=45.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexicon Pharmaceuticals (STU:LX31) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexicon Pharmaceuticals Inc (STU:LX31) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
EYPT MNMD ORIC THRD ENGN MLYS TSHA SVRA IGMS KYTX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
LXRX:USA
Address
2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Website
https://www.lexpharma.com
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Lexicon Pharmaceuticals (STU:LX31) Headlines

No Headlines